tivist, Dr Nutan Thakur, accused Lokayukata (Retd) Justice NK Mehrotra of misusing the state chopper. She also claimed to have lodged a written complain in this regard to Governor Ram Naik,on Saturday. Through a communiqué, Thakur claimed that's ... New Delhi Pioneer, 3 weeks ago
Lok Ayukta retired Justice N K Mehrotra has sent notices to nine district magistrates seeking details of mining and revenue earned in their respective districts in the last five years. The query is part of inquiry related to corruption allegations leveled ...Times of India, 2 months ago
Operator Good day and welcome to the SanDisk Corporation's First Quarter 2015 Financial Results Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Jay Iyer, Investor Relations.Seeking Alpha, 1 month ago J&J's Invokana fends off new SGLT2 rivals to hit $278M in Q1 FiercePharmaMarketing, 1 month ago Johnson & Johnson's (JNJ) Management on Q1 2015 Results - Earnings Call Transcript Seeking Alpha, 1 month ago Johnson & Johnson Reports 2015 First-Quarter Results: Noodls, 1 month ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ:OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that Ravi Mehrotra, Ph.D., has joined the Company as ...FierceBiotech, 33 minutes ago OvaScience Appoints Ravi Mehrotra, Ph.D., as Chief Corporate Development Officer Citybizlist, 3 days ago OvaScience Announces Ravi Mehrotra Ph.D. Joins as Chief Corporate Development Officer PharmiWeb, 3 days ago OVASCIENCE : Announces Ravi Mehrotra, Ph.D., Joins as Chief Corporate Development Officer 4 Traders, 4 days ago
Paper Reviewed Mehrotra, R, Sharma, A., Bari, M., Tuteja, N. and Amirthanathan, G. 2014. An assessment of CMIP5 multi-model decadal hindcasts over Australia from a hydrological viewpoint. Journal of Hydrology 519 : 2932-2951. Prefacing the ...CO2 Science, 1 week ago
SIMPONI® Receives CHMP Positive Opinion For Treatment Of Non-Radiographic Axial Spondyloarthritis In Europe
-- SIMPONI Recommended for Approval in Adult Patients with Severe Active Non-Radiographic Axial Spondyloarthritis LEIDEN, The Netherlands , May 22, 2015 /PRNewswire/ -- Janssen Biologics B.V. ("Janssen") announced today that the Committee for ...ADVFN India, 2 hours ago STELARA® Receives CHMP Positive Opinion for Treatment of Adolescents with Moderate to Severe Psoriasis in Europe Yahoo! UK and Ireland, 1 hour ago
More from: , Ansa.it...and 1 other sources
Johnson & Johnson : Pharmaceutical Segment to Continue Driving Above-Industry Growth with Plans to File More than 10 New Products by 2019, Each with Potential to Exceed $1 Billion in Revenue
Demonstrates ongoing commitment to address the world's most pressing health care needs With a strong in-market portfolio and a robust near-term pipeline, the Pharmaceutical segment is well-positioned to drive continued above-industry compound ...4 Traders, 2 days ago Johnson & Johnson Pharmaceutical Segment to Continue Driving Above-Industry Growth with Plans to File More than 10 New Products by 2019, Each with Potential to Exceed $1 Billion in Revenue FiercePharma, 1 day ago
Sclerostin Quo Vadis? - Is This a Useful Long-Term Mortality Parameter in Prevalent Hemodialysis Patients?
Abstract Background/Aims: Cardiovascular calcification contributes to the increased mortality in hemodialysis patients. Sclerostin was identified as an antianabolic bone factor causing soft tissue calcification. Data on prospective large-scale ...Karger.com, 1 day ago
Janssen Enters into a Worldwide Collaboration with Achillion Pharmaceuticals, Inc. to Combat Hepatitis C Virus
/PRNewswire/ -- Janssen Pharmaceuticals, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has entered into an exclusive worldwide license and collaboration arrangement with Achillion ...TickerTech.com, 2 days ago Johnson & Johnson : Janssen Enters into a Worldwide Collaboration with Achillion Pharmaceuticals, Inc. to Combat Hepatitis C Virus 4 Traders, 2 days ago U.S. FDA Issues Complete Response Letter to sNDA Seeking to Expand the Label for INVEGA SUSTENNA® Industrial Info Financials, 1 week ago Janssen Pharmaceutical Release: U.S. FDA Issues Complete Response Letter To sNDA Seeking To Expand The Label For INVEGA SUSTENNA BioSpace, 1 week ago
Pic Courtesy: - New Delhi: Commodity markets regulator FMC Tuesday approved the appointment of Arun Nanda and S K Mitra as independent directors on the board of MCX. FMC has approved the appointment of Arun Nanda and S K Mitra as Independent ...ZeeNews.com, 2 days ago FMC nod for appointment of two independent directors on MCX board Economic Times, 2 days ago FMC approves appointment of 2 independent directors on MCX board HT Syndication, 2 days ago
on your WebpageAdd Widget >Get your members hooked!